COST-EFFECTIVENESS ANALYSIS OF PEMBROLIZUMAB IN THE TREATMENT OF NON-SMALL CELL LUNG CANCER: A SYSTEMATIC REVIEW. Vietnam Journal of Community Medicine, v. 67, n. 10, 31 Oct.2026.